JG
PACB icon

Jefferies Group’s Pacific Biosciences PACB Stock Holding History

Jefferies Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-100,000
Closed -$740K – 2548
2018
Q4 		$740K Buy
+100,000
New +$634K 0.01% 1307

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jefferies Group's PACB Position: Q3 2022 in Review

Jefferies Group reduced its Pacific Biosciences (PACB) stake by 40% in Q3 2022, selling an estimated $115K and leaving 30,000 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #1385.

Jefferies Group first reported a position in PACB in Q1 2014 and has held it in 8 quarters since. The position peaked at $1.07M in Q1 2019. 227 funds tracked by Wall St. Rank hold PACB as of Q3 2022.

  • Jefferies Group held 30,000 shares of Pacific Biosciences worth $174K as of Q3 2022.
  • Jefferies Group sold 20,000 Pacific Biosciences shares in Q3 2022, an estimated $115K.
  • Pacific Biosciences made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1385 holding.
  • Jefferies Group first reported a position in Pacific Biosciences in Q1 2014 and has held it in 8 quarters since.
  • Jefferies Group's Pacific Biosciences position peaked at $1.07M in Q1 2019.
  • 227 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.